JPMorgan Chase & Co. cut its holdings in Genpact Limited (NYSE:G – Free Report) by 21.8% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 3,213,290 shares of the business services provider’s stock after selling 898,050 shares during the quarter. JPMorgan Chase & Co.’s holdings in Genpact were worth $141,419,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also added to or reduced their stakes in G. Hussman Strategic Advisors Inc. acquired a new position in shares of Genpact during the second quarter worth approximately $3,697,000. Access Investment Management LLC bought a new position in Genpact in the 2nd quarter worth approximately $9,423,000. Strs Ohio lifted its holdings in Genpact by 51.4% during the 2nd quarter. Strs Ohio now owns 56,217 shares of the business services provider’s stock worth $2,474,000 after buying an additional 19,075 shares in the last quarter. Asset Management One Co. Ltd. lifted its holdings in Genpact by 149.5% during the 2nd quarter. Asset Management One Co. Ltd. now owns 33,618 shares of the business services provider’s stock worth $1,480,000 after buying an additional 20,146 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. boosted its position in Genpact by 8.8% in the 2nd quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,501,688 shares of the business services provider’s stock valued at $110,099,000 after buying an additional 203,015 shares during the last quarter. Institutional investors and hedge funds own 96.03% of the company’s stock.
Genpact Stock Performance
Shares of G stock opened at $44.25 on Thursday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.51 and a quick ratio of 1.51. The stock has a market cap of $7.63 billion, a PE ratio of 14.27, a price-to-earnings-growth ratio of 1.43 and a beta of 0.85. The stock has a 50-day moving average of $41.33 and a 200-day moving average of $43.00. Genpact Limited has a one year low of $37.49 and a one year high of $56.76.
Genpact Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 23rd. Investors of record on Tuesday, December 9th will be given a $0.17 dividend. The ex-dividend date is Tuesday, December 9th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.5%. Genpact’s dividend payout ratio is currently 21.94%.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on G shares. JPMorgan Chase & Co. cut their price target on Genpact from $55.00 to $50.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 20th. Wall Street Zen raised Genpact from a “hold” rating to a “buy” rating in a report on Saturday, November 15th. Citigroup raised shares of Genpact to a “hold” rating in a research note on Thursday, October 23rd. Weiss Ratings reissued a “hold (c)” rating on shares of Genpact in a research note on Wednesday, October 8th. Finally, Needham & Company LLC increased their price objective on shares of Genpact from $50.00 to $53.00 and gave the company a “buy” rating in a report on Friday, August 8th. Three research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $51.13.
Insiders Place Their Bets
In other Genpact news, Director Tamara Franklin sold 2,750 shares of Genpact stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $45.65, for a total transaction of $125,537.50. Following the transaction, the director directly owned 22,236 shares in the company, valued at approximately $1,015,073.40. The trade was a 11.01% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Balkrishan Kalra sold 55,000 shares of the business’s stock in a transaction dated Thursday, September 11th. The shares were sold at an average price of $43.36, for a total value of $2,384,800.00. Following the completion of the transaction, the chief executive officer directly owned 295,246 shares of the company’s stock, valued at approximately $12,801,866.56. The trade was a 15.70% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 161,183 shares of company stock worth $6,970,760. 3.07% of the stock is owned by corporate insiders.
Genpact Company Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles
- Five stocks we like better than Genpact
- Options Trading – Understanding Strike Price
- Why Gold Loves Trump as Much as Trump Loves Gold
- What is a penny stock? A comprehensive guide
- Google’s Gemini 3 Sends Broadcom Soaring: TPUs Take Center Stage
- Stock Average Calculator
- Palantir Isn’t Just Riding the AI Boom—It’s Orchestrating It
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
